Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer

Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer

(2015) Kazuhiro Migita et al.   International Journal of Clinical Oncology

Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer

(2014) Eiji Oki et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer

(2013) Akira Tsuburaya et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)

(2013) Yoshiaki Iwasaki et al.   JOURNAL OF SURGICAL ONCOLOGY

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)

(2011) Wasaburo Koizumi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Japanese classification of gastric carcinoma: 3rd English edition

(2011)   Gastric Cancer

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

(2011)   Gastric Cancer

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

(2011) Mitsuru Sasako et al.   JOURNAL OF CLINICAL ONCOLOGY

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes

(2011) Katsunobu Oyama et al.   JOURNAL OF SURGICAL ONCOLOGY

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) A. Okines et al.   ANNALS OF ONCOLOGY

Laparoscopy-Assisted Distal Gastrectomy with Jejunal Pouch Interposition

(2010) Seigo Kitano et al.   ANNALS OF SURGICAL ONCOLOGY

Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer

(2010) M. Degiuli et al.   BRITISH JOURNAL OF SURGERY

A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study)

(2010) T. Yoshikawa et al.   EJSO

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

(2009) Yasushi Sato et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies

(2008) Katja Ott et al.   Gastric Cancer

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer

(2008) Mitsuru Sasako et al.   NEW ENGLAND JOURNAL OF MEDICINE